Last reviewed · How we verify
Prevention of dental caries — Treatment Landscape & Competitive Intelligence
4 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Infuvite Adult | Colecalciferol | Novartis | Vitamin D | Vitamin D3 receptor | 2000-01-01 | |
| M.V.I. Pediatric | RETINOL | Pfizer | Vitamin A | Amyloid beta A4 protein | 1953-01-01 | |
| Drisdol | ERGOCALCIFEROL | Esjay Pharma | Provitamin D2 Compound [EPC] | 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 1941-01-01 | |
| Calciferol | Calciferol | Department of Medical Services Ministry of Public Health of Thailand | Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 3 drugs in Prevention of dental caries
- Department of Medical Services Ministry of Public Health of Thailand · 1 drug in Prevention of dental caries
- Esjay Pharma · 1 drug in Prevention of dental caries
- Novartis · 1 drug in Prevention of dental caries
- Pfizer · 1 drug in Prevention of dental caries
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Prevention of dental caries:
- Prevention of dental caries treatment updates — RSS
- Prevention of dental caries treatment updates — Atom
- Prevention of dental caries treatment updates — JSON
Cite this brief
Drug Landscape (2026). Prevention of dental caries — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-dental-caries. Accessed 2026-06-10.
Related
- Prevention of dental caries full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing